A Study of the Treatment of Recurrent Malignant Glioma With rQNestin34.5v.2
A Study of the Treatment of Recurrent Malignant Glioma With rQNestin34.5v.2
Active, not recruiting · NCT03152318 · Registry updated 2026-03-04Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Study of the Treatment of Recurrent Malignant Glioma With rQNestin34.5v.2 | Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, Pathologic Processes, Pathological Conditions, Signs and Symptoms, anaplastic astrocytoma, astrocytoma (excluding glioblastoma), brain cancer, brain disorder, brain glioma, central nervous system cancer, central nervous system disorder, disease, ependymoma, epithelial neoplasm, ganglioglioma, glioblastoma, glioma, neoplasm, nervous system disorder, neuroepithelial neoplasm, oligoastrocytoma, oligodendroglioma, primitive neuroectodermal tumor | Active, not recruiting | Phase 1 | 2026-03-04 | NCT03152318 |
3 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Candel Therapeutics, Inc. | 6 |
| Dana-Farber Cancer Institute | 324 |
| National Institutes of Health (NIH) | 667 |
5 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Brigham and Women's Hospital | Boston | United States | 60 |
| Dana Farber Cancer Institute | Boston | United States | 133 |
| Johns Hopkins University Medical Center | Baltimore | United States | 2 |
| MD Anderson Cancer Center | Houston | United States | 589 |
| Memorial Sloan Kettering Cancer Center | New York | United States | 1000 |